<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE root>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="other" dtd-version="1.2" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">Russian Journal of Child Neurology</journal-id><journal-title-group><journal-title xml:lang="en">Russian Journal of Child Neurology</journal-title><trans-title-group xml:lang="ru"><trans-title>Русский журнал детской неврологии</trans-title></trans-title-group></journal-title-group><issn publication-format="print">2073-8803</issn><issn publication-format="electronic">2412-9178</issn><publisher><publisher-name xml:lang="en">Publishing House ABV Press</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">193</article-id><article-id pub-id-type="doi">10.17650/2073-8803-2017-12-1-47-55</article-id><article-categories><subj-group subj-group-type="toc-heading" xml:lang="en"><subject>REVIEWS AND LECTURES</subject></subj-group><subj-group subj-group-type="toc-heading" xml:lang="ru"><subject>ОБЗОРЫ И ЛЕКЦИИ</subject></subj-group><subj-group subj-group-type="article-type"><subject></subject></subj-group></article-categories><title-group><article-title xml:lang="en">THE IMPACT OF H YPOTHALAMIC-PITUITARY-ADRENAL SYSTEM HORMONES ON EPILEPTOGENESIS</article-title><trans-title-group xml:lang="ru"><trans-title>Влияние гормонов гипоталамо-гипофизарно-надпочечниковой системы на процессы эпилептогенеза</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Shalkevich</surname><given-names>L. V.</given-names></name><name xml:lang="ru"><surname>Шалькевич</surname><given-names>Л. В.</given-names></name></name-alternatives><address><country country="BY">Belarus</country></address><bio xml:lang="en"><p>3/3 P. Brovka St., Minsk 220013, Republic of Belarus</p></bio><bio xml:lang="ru"><p>Республика Беларусь, 220013 Минск, ул. П. Бровки, 3/3</p></bio><email>shalkevich_@tut.by</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Kudlach</surname><given-names>A. I.</given-names></name><name xml:lang="ru"><surname>Кудлач</surname><given-names>А. И.</given-names></name></name-alternatives><address><country country="BY">Belarus</country></address><bio xml:lang="en"><p>3/3 P. Brovka St., Minsk 220013, Republic of Belarus</p></bio><bio xml:lang="ru"><p>Республика Беларусь, 220013 Минск, ул. П. Бровки, 3/3</p></bio><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Nazarova</surname><given-names>O. P.</given-names></name><name xml:lang="ru"><surname>Назарова</surname><given-names>О. П.</given-names></name></name-alternatives><address><country country="BY">Belarus</country></address><bio xml:lang="en"><p>24 F. Skorina St., Minsk 220114, Republic of Belarus</p></bio><bio xml:lang="ru"><p>Республика Беларусь, 220114 Минск, ул. Ф. Скорины, 24</p></bio><xref ref-type="aff" rid="aff2"/></contrib></contrib-group><aff-alternatives id="aff1"><aff><institution xml:lang="en">Belarusian Medical Academy of Postgraduate Education</institution></aff><aff><institution xml:lang="ru">Белорусская медицинская академия последипломного образования</institution></aff></aff-alternatives><aff-alternatives id="aff2"><aff><institution xml:lang="en">Republican Research and Clinical center of Neurology and Neurosurgery</institution></aff><aff><institution xml:lang="ru">Республиканский научно-практический центр неврологии и нейрохирургии</institution></aff></aff-alternatives><pub-date date-type="pub" iso-8601-date="2017-01-15" publication-format="electronic"><day>15</day><month>01</month><year>2017</year></pub-date><volume>12</volume><issue>1</issue><issue-title xml:lang="en"/><issue-title xml:lang="ru"/><fpage>47</fpage><lpage>55</lpage><history><date date-type="received" iso-8601-date="2017-04-07"><day>07</day><month>04</month><year>2017</year></date><date date-type="accepted" iso-8601-date="2017-04-07"><day>07</day><month>04</month><year>2017</year></date></history><permissions><copyright-statement xml:lang="en">Copyright ©; 2017, ABV-Press</copyright-statement><copyright-statement xml:lang="ru">Copyright ©; 2017, АБВ-пресс</copyright-statement><copyright-year>2017</copyright-year><copyright-holder xml:lang="en">ABV-Press</copyright-holder><copyright-holder xml:lang="ru">АБВ-пресс</copyright-holder><ali:free_to_read xmlns:ali="http://www.niso.org/schemas/ali/1.0/"/><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/">https://rjdn.abvpress.ru/jour/about/editorialPolicies</ali:license_ref></license></permissions><self-uri xlink:href="https://rjdn.abvpress.ru/jour/article/view/193">https://rjdn.abvpress.ru/jour/article/view/193</self-uri><abstract xml:lang="en"><p>Some issues concerning the impact of hypothalamic-pituitary-adrenal system (HPAS) hormones on epileptogenesis are discussed in the article. It was found, that they have a direct and indirect impact. Direct effect implies the reduction of excitation level in the brain cells by affecting membrane channels and receptors involved in the regulation of certain neurotransmitters synthesis. Indirect effect is realized through positive influence on the brain neurons maturation process, leveling the stimulation of excitation processes mediated by biologically active substances, ions and other agents. Adrenocorticotropic hormone and glucocorticosteroids are the main hormones used in antiepileptic therapy. They have an impact both on epileptogenesis itself, and on induction/inhibition of their own effects in accordance with a feedback mechanism of hormones secretion. The mechanism of antiepileptic action of HPAS hormones allows considering them as true antiepileptic drugs for treatment of drug-resistant and special forms of epilepsy.</p></abstract><trans-abstract xml:lang="ru"><p/></trans-abstract><kwd-group xml:lang="en"><kwd>epilepsy</kwd><kwd>hormones</kwd><kwd>hypothalamic-pituitary-adrenal system</kwd><kwd>antiepileptic therapy</kwd></kwd-group><kwd-group xml:lang="ru"><kwd>эпилепсия</kwd><kwd>гормоны</kwd><kwd>гипоталамо-гипофизарно-надпочечниковая система</kwd><kwd>антиэпилептическая терапия</kwd></kwd-group><funding-group/></article-meta></front><body></body><back><ref-list><ref id="B1"><label>1.</label><citation-alternatives><mixed-citation xml:lang="en">1. Айвазян С.О., Лукьянова Е.Г., Ширяев Ю.С. Современные возможности лечения фармакорезистентной эпилепсии у детей. Эпилепсия и пароксизмальные состояния 2014;6(1):34–43. [Ayvazyan S.O., Luk’yanova E.G., Shiryaev Yu.S. Modern treatment options for drug-resistant epilepsy in children. Epilepsiya i paroksizmal’nye sostoyaniya = Epilepsy and Paroxysmal States 2014;6(1):34–43. (In Russ.)].</mixed-citation><mixed-citation xml:lang="ru">Айвазян С.О., Лукьянова Е.Г., Ширяев Ю.С. Современные возможности лечения фармакорезистентной эпилепсии у детей. Эпилепсия и пароксизмальные состояния 2014;6(1):34–43. [Ayvazyan S.O., Luk’yanova E.G., Shiryaev Yu.S. Modern treatment options for drug-resistant epilepsy in children. Epilepsiya i paroksizmal’nye sostoyaniya = Epilepsy and Paroxysmal States 2014;6(1):34–43. (In Russ.)].</mixed-citation></citation-alternatives></ref><ref id="B2"><label>2.</label><citation-alternatives><mixed-citation xml:lang="en">2. Звонкова Н.Г., Балканская С.В., Каркашадзе М.З. и др. Альтернативные методы лечения эпилепсии у детей. Вопросы современной педиатрии 2005;4(4):28–32. [Zvonkova N.G., Balkanskaya S.V., Karkashadze M.Z. et al. Alternative methods of treatment of epilepsy in children. Voprosy sovremennoy pediatrii = Modern Pediatrics Issues 2005;4(4): 28–32. (In Russ.)].</mixed-citation><mixed-citation xml:lang="ru">Звонкова Н.Г., Балканская С.В., Каркашадзе М.З. и др. Альтернативные методы лечения эпилепсии у детей. Вопросы современной педиатрии 2005;4(4):28–32. [Zvonkova N.G., Balkanskaya S.V., Karkashadze M.Z. et al. Alternative methods of treatment of epilepsy in children. Voprosy sovremennoy pediatrii = Modern Pediatrics Issues 2005;4(4): 28–32. (In Russ.)].</mixed-citation></citation-alternatives></ref><ref id="B3"><label>3.</label><citation-alternatives><mixed-citation xml:lang="en">3. Мухин К.Ю., Петрухин А.С., Холин А.А. Эпилептические энцефалопатии и схожие синдромы у детей. М.: Арт- Сервис Лтд, 2011. 680 с. [Mukhin K.Yu., Petrukhin A.S., Kholin A.A. Epileptic encephalopaties and similar syndromes in children. Moscow: ArtService Ltd, 2011. 680 p. (In Russ.)].</mixed-citation><mixed-citation xml:lang="ru">Мухин К.Ю., Петрухин А.С., Холин А.А. Эпилептические энцефалопатии и схожие синдромы у детей. М.: Арт- Сервис Лтд, 2011. 680 с. [Mukhin K.Yu., Petrukhin A.S., Kholin A.A. Epileptic encephalopaties and similar syndromes in children. Moscow: ArtService Ltd, 2011. 680 p. (In Russ.)].</mixed-citation></citation-alternatives></ref><ref id="B4"><label>4.</label><citation-alternatives><mixed-citation xml:lang="en">4. Студеникин В.М., Звонкова Н.Г., Боровик Т.Э. и др. Кетогенная диета при эпилепсии у детей. Вопросы современной педиатрии 2004;1(3): 47–52. [Studenikin V.M., Zvonkova N.G., Borovik T.E. et al. Ketogenic diet in epileptic children. Voprosy sovremennoy pediatrii = Modern Pediatrics Issues 2004;1(3):47–52. (In Russ.)].</mixed-citation><mixed-citation xml:lang="ru">Студеникин В.М., Звонкова Н.Г., Боровик Т.Э. и др. Кетогенная диета при эпилепсии у детей. Вопросы современной педиатрии 2004;1(3): 47–52. [Studenikin V.M., Zvonkova N.G., Borovik T.E. et al. Ketogenic diet in epileptic children. Voprosy sovremennoy pediatrii = Modern Pediatrics Issues 2004;1(3):47–52. (In Russ.)].</mixed-citation></citation-alternatives></ref><ref id="B5"><label>5.</label><citation-alternatives><mixed-citation xml:lang="en">5. Физиология эндокринной системы. Пер. с англ. Под ред. Дж. Гриффина, С. Охеды. М.: Бином. Лаборатория знаний, 2008. 496 с. [Physiology of the endocrine system. Transl. from Engl. Eds. by J. Griffin, S. Ojeda. Moscow: Binom. Laboratoriya znanii, 2008. 496 p. (In Russ.)].</mixed-citation><mixed-citation xml:lang="ru">Физиология эндокринной системы. Пер. с англ. Под ред. Дж. Гриффина, С. Охеды. М.: Бином. Лаборатория знаний, 2008. 496 с. [Physiology of the endocrine system. Transl. from Engl. Eds. by J. Griffin, S. Ojeda. Moscow: Binom. Laboratoriya znanii, 2008. 496 p. (In Russ.)].</mixed-citation></citation-alternatives></ref><ref id="B6"><label>6.</label><citation-alternatives><mixed-citation xml:lang="en">6. Шалькевич Л.В., Шанько Г.Г., Кот Д.А. Кортикостероидная терапия фармакорезистентных эпилепсий у детей. Международный неврологический журнал 2014;3(65):20–7. [Shal’kevich L.V., Shan’ko G.G., Kot D.A. Corticosteroid therapy of drug- resistant epilepsies in children. Mezhdunarodnyy nevrologicheskiy zhurnal = International Neurological Journal 2014;3(65):20–7. (In Russ.)].</mixed-citation><mixed-citation xml:lang="ru">Шалькевич Л.В., Шанько Г.Г., Кот Д.А. Кортикостероидная терапия фармакорезистентных эпилепсий у детей. Международный неврологический журнал 2014;3(65):20–7. [Shal’kevich L.V., Shan’ko G.G., Kot D.A. Corticosteroid therapy of drug- resistant epilepsies in children. Mezhdunarodnyy nevrologicheskiy zhurnal = International Neurological Journal 2014;3(65):20–7. (In Russ.)].</mixed-citation></citation-alternatives></ref><ref id="B7"><label>7.</label><citation-alternatives><mixed-citation xml:lang="en">7. Aicardi J. Clinical approach to the management of intractable epilepsy. Dev Med Child Neurol 1988;30:429–40. PMID: 3049187.</mixed-citation><mixed-citation xml:lang="ru">Aicardi J. Clinical approach to the management of intractable epilepsy. Dev Med Child Neurol 1988;30:429–40. PMID: 3049187.</mixed-citation></citation-alternatives></ref><ref id="B8"><label>8.</label><citation-alternatives><mixed-citation xml:lang="en">8. Aldenhoff J.B., Gruol D.L., Rivier J. et al. Corticotropin releasing factor decreases postburst hyperpolarizations and excites hippocampal neurons. Science 1983;221(4613):875–7. PMID: 6603658.</mixed-citation><mixed-citation xml:lang="ru">Aldenhoff J.B., Gruol D.L., Rivier J. et al. Corticotropin releasing factor decreases postburst hyperpolarizations and excites hippocampal neurons. Science 1983;221(4613):875–7. PMID: 6603658.</mixed-citation></citation-alternatives></ref><ref id="B9"><label>9.</label><citation-alternatives><mixed-citation xml:lang="en">9. Ardeleanu A., Sterescu N. RNA and DNA synthesis in developing rat brain: hormonal influences. Psychoneuroendocrinol 1978;3(1):93–101. PMID: 2055895.</mixed-citation><mixed-citation xml:lang="ru">Ardeleanu A., Sterescu N. RNA and DNA synthesis in developing rat brain: hormonal influences. Psychoneuroendocrinol 1978;3(1):93–101. PMID: 2055895.</mixed-citation></citation-alternatives></ref><ref id="B10"><label>10.</label><citation-alternatives><mixed-citation xml:lang="en">10. Avishai-Eliner S., Yi S.J., Baram T.Z. Developmental profile of messenger RNA for corticotropin-releasing hormone in the rat limbic system. Brain Res Dev Brain Res 1996;91(2):159–63. PMID: 8852365.</mixed-citation><mixed-citation xml:lang="ru">Avishai-Eliner S., Yi S.J., Baram T.Z. Developmental profile of messenger RNA for corticotropin-releasing hormone in the rat limbic system. Brain Res Dev Brain Res 1996;91(2):159–63. PMID: 8852365.</mixed-citation></citation-alternatives></ref><ref id="B11"><label>11.</label><citation-alternatives><mixed-citation xml:lang="en">11. Baram T.Z., Hatalski C.G. Neuropeptidemediated excitability: a key triggering mechanism for seizure generation in the developing brain. Trends Neurosci 1998;21(11):471–6. PMID: 9829688.</mixed-citation><mixed-citation xml:lang="ru">Baram T.Z., Hatalski C.G. Neuropeptidemediated excitability: a key triggering mechanism for seizure generation in the developing brain. Trends Neurosci 1998;21(11):471–6. PMID: 9829688.</mixed-citation></citation-alternatives></ref><ref id="B12"><label>12.</label><citation-alternatives><mixed-citation xml:lang="en">12. Brunson K.L., Avishai-Eliner S., Baram T.Z. ACTH treatment of infantile spasms: mechanisms of its effects in modulation of neuronal excitability. Int Rev Neurobiol 2002;49:185–97. PMID: 12040892.</mixed-citation><mixed-citation xml:lang="ru">Brunson K.L., Avishai-Eliner S., Baram T.Z. ACTH treatment of infantile spasms: mechanisms of its effects in modulation of neuronal excitability. Int Rev Neurobiol 2002;49:185–97. PMID: 12040892.</mixed-citation></citation-alternatives></ref><ref id="B13"><label>13.</label><citation-alternatives><mixed-citation xml:lang="en">13. Dumermuth G. Uber die Blitz-Nick-Salaam-Krampfe und ihre Behandlung mit ACTH und hydrocortison. Vorlaufige Mitteilung. Helv Paediatr Acta 1959;14:250–70. PMID: 13818581.</mixed-citation><mixed-citation xml:lang="ru">Dumermuth G. Uber die Blitz-Nick-Salaam-Krampfe und ihre Behandlung mit ACTH und hydrocortison. Vorlaufige Mitteilung. Helv Paediatr Acta 1959;14:250–70. PMID: 13818581.</mixed-citation></citation-alternatives></ref><ref id="B14"><label>14.</label><citation-alternatives><mixed-citation xml:lang="en">14. Dunwiddie T.V., Fredholm B.B. Adenosine neuromodulation. In: Purinergic approaches in experimental therapeutics. Eds. by K.A. Jacobson, M.F. Jarvis. New York: Wiley Liss, 1997. Pp. 359–382.</mixed-citation><mixed-citation xml:lang="ru">Dunwiddie T.V., Fredholm B.B. Adenosine neuromodulation. In: Purinergic approaches in experimental therapeutics. Eds. by K.A. Jacobson, M.F. Jarvis. New York: Wiley Liss, 1997. Pp. 359–382.</mixed-citation></citation-alternatives></ref><ref id="B15"><label>15.</label><citation-alternatives><mixed-citation xml:lang="en">15. Gastaut H., Saltiel J., Raybaud C. et al. A propos du traitement par l’ACTH des encephalites myoclonique de la premiere enfance avec majeure (hypsarhythmia). Pediatrie 1959;14(1):35–41. PMID: 13633380.</mixed-citation><mixed-citation xml:lang="ru">Gastaut H., Saltiel J., Raybaud C. et al. A propos du traitement par l’ACTH des encephalites myoclonique de la premiere enfance avec majeure (hypsarhythmia). Pediatrie 1959;14(1):35–41. PMID: 13633380.</mixed-citation></citation-alternatives></ref><ref id="B16"><label>16.</label><citation-alternatives><mixed-citation xml:lang="en">16. Giorgi F.S., Pizzanelli C., Biagioni F. et al. The role of norepinephrine in epilepsy: from the bench to the bedside. Neurosci Biobehav Rev 2004;28(5):507–24. DOI: 10.1016/j.neubiorev.2004.06.008. PMID: 15465138.</mixed-citation><mixed-citation xml:lang="ru">Giorgi F.S., Pizzanelli C., Biagioni F. et al. The role of norepinephrine in epilepsy: from the bench to the bedside. Neurosci Biobehav Rev 2004;28(5):507–24. DOI: 10.1016/j.neubiorev.2004.06.008. PMID: 15465138.</mixed-citation></citation-alternatives></ref><ref id="B17"><label>17.</label><citation-alternatives><mixed-citation xml:lang="en">17. Haas H.L., Greene R.W. Endogenous adenosine inhibits hyppocampal CA1 neurones: further evidence from extra- and intracellular recording. Naunyn-Schmiedeberg’s Arch Pharmacol 1988;337(5):561–5. PMID: 3412493.</mixed-citation><mixed-citation xml:lang="ru">Haas H.L., Greene R.W. Endogenous adenosine inhibits hyppocampal CA1 neurones: further evidence from extra- and intracellular recording. Naunyn-Schmiedeberg’s Arch Pharmacol 1988;337(5):561–5. PMID: 3412493.</mixed-citation></citation-alternatives></ref><ref id="B18"><label>18.</label><citation-alternatives><mixed-citation xml:lang="en">18. Hollrigel G.S., Chen K., Baram T.Z. et al. The pro-convulsant actions of corticotropin- releasing hormone in the hippocampus of infant rats. Neurosci 1998;84(1):71–9. PMID: 9522363.</mixed-citation><mixed-citation xml:lang="ru">Hollrigel G.S., Chen K., Baram T.Z. et al. The pro-convulsant actions of corticotropin- releasing hormone in the hippocampus of infant rats. Neurosci 1998;84(1):71–9. PMID: 9522363.</mixed-citation></citation-alternatives></ref><ref id="B19"><label>19.</label><citation-alternatives><mixed-citation xml:lang="en">19. Huttenlocher P.R., Amemiya I.M. Effect of adrenocortical steroids and of adrenocorticotrophic hormone on (Na+/K+)- ATP-ase in immature cerebral cortex. Pediatr Res 1978;12(2):104–7. DOI: 10.1203/00006450-197802000-00008. PMID: 205825.</mixed-citation><mixed-citation xml:lang="ru">Huttenlocher P.R., Amemiya I.M. Effect of adrenocortical steroids and of adrenocorticotrophic hormone on (Na+/K+)- ATP-ase in immature cerebral cortex. Pediatr Res 1978;12(2):104–7. DOI: 10.1203/00006450-197802000-00008. PMID: 205825.</mixed-citation></citation-alternatives></ref><ref id="B20"><label>20.</label><citation-alternatives><mixed-citation xml:lang="en">20. Iacobas D.A., Iacobas S., Chachua T. et al. Prenatal corticosteroids modify glutamatergic and GABAergic synapse genomic fabric: insights from a novel animal model of infantile spasms. J Neuroendocrinol 2013;25(11):964–79. DOI: 10.1111/jne.12061. PMID: 23763471.</mixed-citation><mixed-citation xml:lang="ru">Iacobas D.A., Iacobas S., Chachua T. et al. Prenatal corticosteroids modify glutamatergic and GABAergic synapse genomic fabric: insights from a novel animal model of infantile spasms. J Neuroendocrinol 2013;25(11):964–79. DOI: 10.1111/jne.12061. PMID: 23763471.</mixed-citation></citation-alternatives></ref><ref id="B21"><label>21.</label><citation-alternatives><mixed-citation xml:lang="en">21. Irani S.R., Buckley C., Vincent A. et al. Immunotherapy-responsive seizure-like episodes with potassium channel antibodies. Neurology 2008;71(20):1647–8. DOI: 10.1212/01.wnl.0000326572.93762.51. PMID: 18815385.</mixed-citation><mixed-citation xml:lang="ru">Irani S.R., Buckley C., Vincent A. et al. Immunotherapy-responsive seizure-like episodes with potassium channel antibodies. Neurology 2008;71(20):1647–8. DOI: 10.1212/01.wnl.0000326572.93762.51. PMID: 18815385.</mixed-citation></citation-alternatives></ref><ref id="B22"><label>22.</label><citation-alternatives><mixed-citation xml:lang="en">22. Jarvis M.F., Williams M. Adenosine in central nervous system function. In: Adenosine and adenosine receptors. Ed. by M. Williams. Clifton: The Humana Press, 1990. Pp. 423–474.</mixed-citation><mixed-citation xml:lang="ru">Jarvis M.F., Williams M. Adenosine in central nervous system function. In: Adenosine and adenosine receptors. Ed. by M. Williams. Clifton: The Humana Press, 1990. Pp. 423–474.</mixed-citation></citation-alternatives></ref><ref id="B23"><label>23.</label><citation-alternatives><mixed-citation xml:lang="en">23. Klein R., Livingston S. The effect of adrenocorticotrophic hormones in epilepsy. J Pediatr 1950;37(5):733–42. PMID: 14784927.</mixed-citation><mixed-citation xml:lang="ru">Klein R., Livingston S. The effect of adrenocorticotrophic hormones in epilepsy. J Pediatr 1950;37(5):733–42. PMID: 14784927.</mixed-citation></citation-alternatives></ref><ref id="B24"><label>24.</label><citation-alternatives><mixed-citation xml:lang="en">24. Low N.L. Infantile spasms with mental retardation. II. Treatment with cortisone and adrenocorticotropin. Pediatrics 1958;22(6):1165–9. PMID: 13613851.</mixed-citation><mixed-citation xml:lang="ru">Low N.L. Infantile spasms with mental retardation. II. Treatment with cortisone and adrenocorticotropin. Pediatrics 1958;22(6):1165–9. PMID: 13613851.</mixed-citation></citation-alternatives></ref><ref id="B25"><label>25.</label><citation-alternatives><mixed-citation xml:lang="en">25. Marver D. Evidence of corticosteroid action along the nephron. Am J Physiol 1984;246(2):111–23. PMID: 6320678.</mixed-citation><mixed-citation xml:lang="ru">Marver D. Evidence of corticosteroid action along the nephron. Am J Physiol 1984;246(2):111–23. PMID: 6320678.</mixed-citation></citation-alternatives></ref><ref id="B26"><label>26.</label><citation-alternatives><mixed-citation xml:lang="en">26. McKnight K., Jiang Y., Hart Y. et al. Serum antibodies in epilepsy and seizure-associated disorders. Neurol 2005;65(11):1730–6. DOI: 10.1212/01.wnl.0000187129.66353.13. PMID: 16344514.</mixed-citation><mixed-citation xml:lang="ru">McKnight K., Jiang Y., Hart Y. et al. Serum antibodies in epilepsy and seizure-associated disorders. Neurol 2005;65(11):1730–6. DOI: 10.1212/01.wnl.0000187129.66353.13. PMID: 16344514.</mixed-citation></citation-alternatives></ref><ref id="B27"><label>27.</label><citation-alternatives><mixed-citation xml:lang="en">27. McQuarrie I., Anderson J.A., Ziegler M.R. Observation on the antagonistic effects of posterior pituitary and cortico-adrenal hormones in the epileptic subject. J Clin Endocrinol 1942;2: 406–10.</mixed-citation><mixed-citation xml:lang="ru">McQuarrie I., Anderson J.A., Ziegler M.R. Observation on the antagonistic effects of posterior pituitary and cortico-adrenal hormones in the epileptic subject. J Clin Endocrinol 1942;2: 406–10.</mixed-citation></citation-alternatives></ref><ref id="B28"><label>28.</label><citation-alternatives><mixed-citation xml:lang="en">28. Munakata M. et al. Reduction in glutamine/glutamate levels in the cerebral cortex after adrenocorticotropic hormone therapy in patients with West syndrome. Tohoku J Exp Med 2014;232(4):277–83. PMID: 24705707.</mixed-citation><mixed-citation xml:lang="ru">Munakata M. et al. Reduction in glutamine/glutamate levels in the cerebral cortex after adrenocorticotropic hormone therapy in patients with West syndrome. Tohoku J Exp Med 2014;232(4):277–83. PMID: 24705707.</mixed-citation></citation-alternatives></ref><ref id="B29"><label>29.</label><citation-alternatives><mixed-citation xml:lang="en">29. Molteni R., Fumagalli F., Magnaghi V. et al. Modulation of fibroblast growth factor- 2 by stress and corticosteroids: from developmental events to adult brain plasticity. Brain Res Brain Res Rev 2001;37 (1–3):249–58. PMID: 11744090.</mixed-citation><mixed-citation xml:lang="ru">Molteni R., Fumagalli F., Magnaghi V. et al. Modulation of fibroblast growth factor- 2 by stress and corticosteroids: from developmental events to adult brain plasticity. Brain Res Brain Res Rev 2001;37 (1–3):249–58. PMID: 11744090.</mixed-citation></citation-alternatives></ref><ref id="B30"><label>30.</label><citation-alternatives><mixed-citation xml:lang="en">30. O’Regan M.E., Brown J.K. Is ACTH a key to understanding anticonvulsant action? Dev Med Child Neurol 1998;40(2):82–9. PMID: 9489495.</mixed-citation><mixed-citation xml:lang="ru">O’Regan M.E., Brown J.K. Is ACTH a key to understanding anticonvulsant action? Dev Med Child Neurol 1998;40(2):82–9. PMID: 9489495.</mixed-citation></citation-alternatives></ref><ref id="B31"><label>31.</label><citation-alternatives><mixed-citation xml:lang="en">31. Palo J., Savolainen H. The effect of high doses of synthetic ACTH on rat brain. Brain Res 1974;70(2):313–20. PMID: 4363491.</mixed-citation><mixed-citation xml:lang="ru">Palo J., Savolainen H. The effect of high doses of synthetic ACTH on rat brain. Brain Res 1974;70(2):313–20. PMID: 4363491.</mixed-citation></citation-alternatives></ref><ref id="B32"><label>32.</label><citation-alternatives><mixed-citation xml:lang="en">32. Prazantelli M.R. On the molecular mechanism of adrenocorticotropic hormone in the CNS: neurotransmitters and receptors. Exp Neurol 1994;125(1):142–61. DOI: 10.1006/exnr.1994.1018. PMID: 7905835.</mixed-citation><mixed-citation xml:lang="ru">Prazantelli M.R. On the molecular mechanism of adrenocorticotropic hormone in the CNS: neurotransmitters and receptors. Exp Neurol 1994;125(1):142–61. DOI: 10.1006/exnr.1994.1018. PMID: 7905835.</mixed-citation></citation-alternatives></ref><ref id="B33"><label>33.</label><citation-alternatives><mixed-citation xml:lang="en">33. Riikonen M.R., Soderstrom S., Vanhala R. et al. West syndrome: cerebrospinal fluid nerve growth factor and effect of ACTH. Pediatr Neurol 1997;17(3):224–9. PMID: 9390698.</mixed-citation><mixed-citation xml:lang="ru">Riikonen M.R., Soderstrom S., Vanhala R. et al. West syndrome: cerebrospinal fluid nerve growth factor and effect of ACTH. Pediatr Neurol 1997;17(3):224–9. PMID: 9390698.</mixed-citation></citation-alternatives></ref><ref id="B34"><label>34.</label><citation-alternatives><mixed-citation xml:lang="en">34. Sorel L., Dusaucy-Bauloye A. A propos de 21 cas d’hypsarhythmie de Gibbs: son traitement spectaculaire par I'ACTH. Acta Neurol Psychiatr Belg 1958;58(2):130. PMID: 13532578.</mixed-citation><mixed-citation xml:lang="ru">Sorel L., Dusaucy-Bauloye A. A propos de 21 cas d’hypsarhythmie de Gibbs: son traitement spectaculaire par I'ACTH. Acta Neurol Psychiatr Belg 1958;58(2):130. PMID: 13532578.</mixed-citation></citation-alternatives></ref><ref id="B35"><label>35.</label><citation-alternatives><mixed-citation xml:lang="en">35. Stamps F.W., Gibbs E.L., Rosenthal I.M. et al. Treatment of hypsarrhythmia with ACTH. J Am Med Assoc 1959;171: 408–11. PMID: 13833723.</mixed-citation><mixed-citation xml:lang="ru">Stamps F.W., Gibbs E.L., Rosenthal I.M. et al. Treatment of hypsarrhythmia with ACTH. J Am Med Assoc 1959;171: 408–11. PMID: 13833723.</mixed-citation></citation-alternatives></ref><ref id="B36"><label>36.</label><citation-alternatives><mixed-citation xml:lang="en">36. Storm van Leeuwen W., Lopes da Silva F.H., de Weid D. A frequency shift in the hippocampal teta activity: an electrical correlate of central action of ACTH analogues in the dog? Brain Res 1974;69(2):361–5. PMID: 4362816.</mixed-citation><mixed-citation xml:lang="ru">Storm van Leeuwen W., Lopes da Silva F.H., de Weid D. A frequency shift in the hippocampal teta activity: an electrical correlate of central action of ACTH analogues in the dog? Brain Res 1974;69(2):361–5. PMID: 4362816.</mixed-citation></citation-alternatives></ref><ref id="B37"><label>37.</label><citation-alternatives><mixed-citation xml:lang="en">37. Urban I., de Weid D. Changes in excitability of the theta generating substrate by ACTH 4–10 in the rat. Exp Brain Res 1976;24:325–34. PMID: 176046.</mixed-citation><mixed-citation xml:lang="ru">Urban I., de Weid D. Changes in excitability of the theta generating substrate by ACTH 4–10 in the rat. Exp Brain Res 1976;24:325–34. PMID: 176046.</mixed-citation></citation-alternatives></ref><ref id="B38"><label>38.</label><citation-alternatives><mixed-citation xml:lang="en">38. Vaughan C.J., Delanty N. Pathophysiology of acute symptomatic seizures. In: Seizures: Medical Causes and Management. Ed. by N. Delanty. The Humana Press: Totowa, NJ, 2002. Pp. 7–24.</mixed-citation><mixed-citation xml:lang="ru">Vaughan C.J., Delanty N. Pathophysiology of acute symptomatic seizures. In: Seizures: Medical Causes and Management. Ed. by N. Delanty. The Humana Press: Totowa, NJ, 2002. Pp. 7–24.</mixed-citation></citation-alternatives></ref><ref id="B39"><label>39.</label><citation-alternatives><mixed-citation xml:lang="en">39. Vreugdenhil E., de Kloet E.R., Schaaf M. et al. Genetic dissection of corticosterone receptor function in the rat hippocampus. Eur Neuropsychopharmacol 2001;11(6):423–30. PMID: 11704419.</mixed-citation><mixed-citation xml:lang="ru">Vreugdenhil E., de Kloet E.R., Schaaf M. et al. Genetic dissection of corticosterone receptor function in the rat hippocampus. Eur Neuropsychopharmacol 2001;11(6):423–30. PMID: 11704419.</mixed-citation></citation-alternatives></ref><ref id="B40"><label>40.</label><citation-alternatives><mixed-citation xml:lang="en">40. Weissmann G., Thomas L. Studies on lysosomes. II. The effect of cortisone on the release of acid hydrolases from a large granule fraction of rabbit liver induced by an excess of vitamin A. J Clin Invest 1963;42(5):661–9. DOI: 10.1172/JCI104757. PMID: 13999782.</mixed-citation><mixed-citation xml:lang="ru">Weissmann G., Thomas L. Studies on lysosomes. II. The effect of cortisone on the release of acid hydrolases from a large granule fraction of rabbit liver induced by an excess of vitamin A. J Clin Invest 1963;42(5):661–9. DOI: 10.1172/JCI104757. PMID: 13999782.</mixed-citation></citation-alternatives></ref><ref id="B41"><label>41.</label><citation-alternatives><mixed-citation xml:lang="en">41. Zhang Y., Zou L.P., Ding Y.X. et al. Association of SCN1A gene polymorphisms with infantile spasms and adrenocorticotropic hormone responsiveness. Eur Rev Med Pharmacol Sci 2014;18(17):2500–6. PMID: 25268096.</mixed-citation><mixed-citation xml:lang="ru">Zhang Y., Zou L.P., Ding Y.X. et al. Association of SCN1A gene polymorphisms with infantile spasms and adrenocorticotropic hormone responsiveness. Eur Rev Med Pharmacol Sci 2014;18(17):2500–6. PMID: 25268096.</mixed-citation></citation-alternatives></ref></ref-list></back></article>
